liso-cel
bms
['pilot', 'ovarian']
personal organoids could help individualize treatment for patients with ovarian cancer according to pilot data reported at #aacr23 by researchers. research summary #ovariancancer 
Your official source for @DanaFarber Cancer Institute news | Research, science, and innovation | Media requests: media@dfci.harvard.edu or 617-632-4090